Lansoprazole indications: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
(No difference)
|
Revision as of 15:00, 20 December 2011
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
PREVACID® NapraPACTM (250, 375 or 500) is indicated for reducing the risk of NSAID-associated
gastric ulcers in patients with a history of documented gastric ulcer who require the use of an NSAID
for treatment of the signs and symptoms of rheumatoid arthritis, osteoarthritis, and ankylosing
spondylitis.
Adapted from the FDA Package Insert.